CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CALC CALCIMEDICA

Market Closed 12-19 16:00:00 EST

6.35

+1.45

+29.59%

盘后6.10

-0.25-3.94%

19:51 EST

High6.40	Low4.86	Vol223.96K
Open4.91	D1 Closing4.90	Amplitude31.43%
Mkt Cap91.50M	Tradable Cap42.52M	Total Shares14.41M
T/O1.29M	T/O Rate3.34%	Tradable Shares6.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":6.35,"timestamp":1766178000000,"preClose":4.9,"halted":0,"volume":223962,"hourTrading":{"tag":"盘后","latestPrice":6.1,"preClose":6.35,"latestTime":"19:51 EST","volume":2400,"amount":14742.1909,"timestamp":1766191888765},"delay":0,"floatShares":6696300,"shares":14409400,"eps":-1.613603,"marketStatus":"Market Closed","change":1.45,"latestTime":"12-19 16:00:00 EST","open":4.91,"high":6.4,"low":4.8601,"amount":1286111.9976672,"amplitude":0.314265,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.613603,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":4.9,"preHourTrading":{"tag":"盘前","latestPrice":4.96,"preClose":4.9,"latestTime":"08:08 EST","volume":32,"amount":158.6499936,"timestamp":1766149703221},"postHourTrading":{"tag":"盘后","latestPrice":6.1,"preClose":6.35,"latestTime":"19:51 EST","volume":2400,"amount":14742.1909,"timestamp":1766191888765},"volumeRatio":2.529763656018855},"requestUrl":"/m/hq/s/CALC/tweets","defaultTab":"tweets","newsList":[{"id":"2584291026","title":"Oppenheimer Reaffirms Their Buy Rating on CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584291026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584291026?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:55","pubTimestamp":1763387722,"startTime":"0","endTime":"0","summary":"In a report released on November 14, Leland Gershell from Oppenheimer maintained a Buy rating on CalciMedica, with a price target of $20.00. The co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-calcimedica-calc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-calcimedica-calc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","CALC"],"gpt_icon":0},{"id":"2582637560","title":"CalciMedica reports Q3 net loss of $7.8 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582637560","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582637560?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:15","pubTimestamp":1762949753,"startTime":"0","endTime":"0","summary":"CalciMedica reports Q3 net loss of $7.8 mlnOverviewCalciMedica reports Q3 net loss of $7.8 mln vs $5.6 mln year-agoPositive FDA discussions on pivotal trial for acute pancreatitis, design expected 1H ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2582937321","title":"CalciMedica Q3 EPS $(0.52) Misses $(0.42) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582937321","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582937321?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:03","pubTimestamp":1762949025,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.42) by 22.93 percent. This is a 4 percent decrease over losses of $(0.50) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48799005/calcimedica-q3-eps-0-52-misses-0-42-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain",".IXIC","QID","NQmain","PSQ","TQQQ","TSYW.SI","USAW.SI","USJW.SI","BK4007","NVIW.SI","CALC","QLD","SQQQ"],"gpt_icon":0},{"id":"2582373023","title":"CalciMedica Launches Phase 2 KOURAGE Trial of Auxora in Acute Kidney Injury with Respiratory Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373023","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373023?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:02","pubTimestamp":1762948973,"startTime":"0","endTime":"0","summary":"CalciMedica Inc. has announced ongoing enrollment in its Phase 2 KOURAGE trial, evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury  with respiratory failure. The company plans to enroll 150 patients, with data expected in the first half of 2026. Additionally, CalciMedica reported positive discussions with the U.S. Food and Drug Administration  regarding the design of a pivotal trial in acute pancreatitis , with final trial design anticipated in the first half of 2026. In November 2025, preclinical results on Auxora were presented at the American Society of Nephrology  Kidney Week, showing improved kidney function and reduced renal injury in a rat model of AKI. CalciMedica has also entered a collaboration with Telperian to utilize AI insights in support of its AP pivotal trial design.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2Gz9x9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2582537301","title":"CalciMedica Reports Preclinical Success for CRAC Channel Inhibitor in Pulmonary Arterial Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2582537301","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582537301?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:02","pubTimestamp":1762948931,"startTime":"0","endTime":"0","summary":"CalciMedica Inc. has announced the publication of preclinical data in JCI Insight supporting its proprietary CRAC channel inhibitor, CM5480, as a potential therapy for pulmonary arterial hypertension . The study, conducted in collaboration with leading PAH researchers in France, evaluated CM5480 as both a monotherapy and in combination with standard-of-care PAH treatments in an animal model. The results indicate that CM5480 may mitigate pulmonary hypertension and associated cardiac dysfunction. These preclinical findings have been published, and clinical data from ongoing studies of CalciMedica's lead candidate, Auxora, in acute kidney injury are expected in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL10jX1G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2582537347","title":"CalciMedica Q3 Operating Expenses USD 5.618 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582537347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582537347?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:01","pubTimestamp":1762948861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX9B2B99:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2582373421","title":"CalciMedica Q3 Basic EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373421?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:01","pubTimestamp":1762948861,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX9B2B99:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2582373202","title":"CalciMedica Inc - Cash Position Expected to Fund Operations Into 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373202?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:01","pubTimestamp":1762948861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX9B2B99:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2582873923","title":"CalciMedica Reports Auxora Improves Kidney Function in Preclinical AKI Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873923","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873923?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:03","pubTimestamp":1762776217,"startTime":"0","endTime":"0","summary":"CalciMedica Inc., a clinical-stage biopharmaceutical company, announced the presentation of new preclinical data on its calcium release-activated calcium  channel inhibitor, Auxora, at the American Society of Nephrology  Kidney Week 2025. The results, already presented, demonstrated that treatment with Auxora significantly reduced IL-17-related inflammation in both the kidney and lung, increased glomerular filtration rate , and decreased renal injury in a rat model of acute kidney injury . These findings support the ongoing clinical evaluation of Auxora in the Phase 2 KOURAGE trial for patients with severe AKI and acute hypoxemic respiratory failure . The full presentation is available on CalciMedica's investor relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLbXHjyD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2581884329","title":"CalciMedica Inc  expected to post a loss of 41 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581884329","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581884329?lang=en_us&edition=fundamental","pubTime":"2025-11-07 23:11","pubTimestamp":1762528265,"startTime":"0","endTime":"0","summary":"CalciMedica Inc  expected to post a loss of41cents a share - Earnings Preview CalciMedica Inc CALC.OQ CALC.O is expected to  show no change in quarterly revenue when it reports  results on November 11","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ23Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2581045850","title":"CalciMedica Boosts Stock Offering to $9.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581045850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581045850?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:39","pubTimestamp":1762465177,"startTime":"0","endTime":"0","summary":"The latest announcement is out from CalciMedica ( ($CALC) ). On November 6, 2025, CalciMedica, Inc. announced an increase in the maximum aggregate ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-boosts-stock-offering-to-9-7-million?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-boosts-stock-offering-to-9-7-million?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2575914962","title":"CalciMedica and Telperian Announce AI Collaboration to Enhance Auxora Clinical Trial Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2575914962","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575914962?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:01","pubTimestamp":1760439719,"startTime":"0","endTime":"0","summary":"CalciMedica Inc., a clinical-stage biopharmaceutical company, has announced a collaboration with Telperian, a clinical trial intelligence company. The partnership will integrate Telperian's artificial intelligence engine into the analysis of clinical trial datasets from completed studies of Auxora, CalciMedica's investigational therapy for acute inflammatory and immunologic illnesses. The AI tools will help refine target patient populations and efficacy endpoints for upcoming pivotal trials, providing detailed insights into treatment effects and enhancing the design of future clinical programs. The findings from this collaboration will also support regulatory discussions with the FDA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDLzS1KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2569110711","title":"CalciMedica Inc.'s Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2569110711","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569110711?lang=en_us&edition=fundamental","pubTime":"2025-09-23 23:31","pubTimestamp":1758641482,"startTime":"0","endTime":"0","summary":"Eric W. Roberts, Chief Business Officer and Director at CalciMedica Inc., reported an acquisition of common shares of CalciMedica Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL6FrJMd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CalciMedica Inc.'s Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2567122032","title":"CalciMedica’s CBO Makes Bold Stock Purchase!","url":"https://stock-news.laohu8.com/highlight/detail?id=2567122032","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567122032?lang=en_us&edition=fundamental","pubTime":"2025-09-16 10:08","pubTimestamp":1757988488,"startTime":"0","endTime":"0","summary":"New insider activity at CalciMedica ( ($CALC) ) has taken place on September 15, 2025. Eric W. Roberts, the Chief Business Officer of CalciMedica, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/calcimedicas-cbo-makes-bold-stock-purchase-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/calcimedicas-cbo-makes-bold-stock-purchase-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2567145014","title":"Eric W. Roberts, Chief Business Officer, Reports Acquisition of CalciMedica Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2567145014","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567145014?lang=en_us&edition=fundamental","pubTime":"2025-09-16 00:32","pubTimestamp":1757953944,"startTime":"0","endTime":"0","summary":"Eric W. Roberts, Chief Business Officer and Director of CalciMedica Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDLcdbQCm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Eric W. Roberts, Chief Business Officer, Reports Acquisition of CalciMedica Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2566997091","title":"Eric W. Roberts, Chief Business Officer, Acquires Common Shares of CalciMedica Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2566997091","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566997091?lang=en_us&edition=fundamental","pubTime":"2025-09-12 00:00","pubTimestamp":1757606443,"startTime":"0","endTime":"0","summary":"Eric W. Roberts, the Chief Business Officer and a Director of CalciMedica Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL65Mgzz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Eric W. Roberts, Chief Business Officer, Acquires Common Shares of CalciMedica Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2564438438","title":"Eric W. Roberts, Chief Business Officer of CalciMedica Inc., Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2564438438","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564438438?lang=en_us&edition=fundamental","pubTime":"2025-09-03 01:05","pubTimestamp":1756832758,"startTime":"0","endTime":"0","summary":"Eric W. Roberts, Chief Business Officer and Director of CalciMedica Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL7GGDVG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Eric W. Roberts, Chief Business Officer of CalciMedica Inc., Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2562242009","title":"Eric W. Roberts, Chief Business Officer, Reports Acquisition of Common Shares in CalciMedica Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2562242009","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562242009?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:30","pubTimestamp":1756128640,"startTime":"0","endTime":"0","summary":"Eric W. Roberts, the Chief Business Officer and a Director of CalciMedica Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL8YnHsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Eric W. Roberts, Chief Business Officer, Reports Acquisition of Common Shares in CalciMedica Inc","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2561947504","title":"CalciMedica Inc.'s Chief Medical Officer Sudarshan Hebbar Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561947504","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561947504?lang=en_us&edition=fundamental","pubTime":"2025-08-22 00:00","pubTimestamp":1755792058,"startTime":"0","endTime":"0","summary":"Sudarshan Hebbar, Chief Medical Officer of CalciMedica Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL4md6Md:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2560511936","title":"CalciMedica Inc. Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2560511936","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560511936?lang=en_us&edition=fundamental","pubTime":"2025-08-20 01:45","pubTimestamp":1755625543,"startTime":"0","endTime":"0","summary":"Eric W. Roberts, the Chief Business Officer and a Director of CalciMedica Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL4WB4fs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CalciMedica Inc. Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calcimedica.com","stockEarnings":[{"period":"1week","weight":0.4665},{"period":"1month","weight":1.012},{"period":"3month","weight":1.1026},{"period":"6month","weight":2.872},{"period":"1year","weight":1.2924},{"period":"ytd","weight":0.7938}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.284777},{"month":2,"riseRate":0,"avgChangeRate":-0.21989},{"month":3,"riseRate":0,"avgChangeRate":-0.267862},{"month":4,"riseRate":0.2,"avgChangeRate":-0.060527},{"month":5,"riseRate":0.4,"avgChangeRate":-0.021756},{"month":6,"riseRate":0.4,"avgChangeRate":0.018521},{"month":7,"riseRate":0.4,"avgChangeRate":0.171537},{"month":8,"riseRate":0.4,"avgChangeRate":-0.074652},{"month":9,"riseRate":0.6,"avgChangeRate":-0.007161},{"month":10,"riseRate":0.4,"avgChangeRate":-0.031218},{"month":11,"riseRate":0.333333,"avgChangeRate":0.111978},{"month":12,"riseRate":0.666667,"avgChangeRate":0.030839}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}